APA (7th ed.) Citation

Wang, L., Wang, Q., Xu, Y., Cui, M., & Han, L. (2020). Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance. Current drug targets, 21(2), 167. https://doi.org/10.2174/1389450120666190925123507

Chicago Style (17th ed.) Citation

Wang, Ling, Qi Wang, Yangchun Xu, Manhua Cui, and Liying Han. "Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance." Current Drug Targets 21, no. 2 (2020): 167. https://doi.org/10.2174/1389450120666190925123507.

MLA (9th ed.) Citation

Wang, Ling, et al. "Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance." Current Drug Targets, vol. 21, no. 2, 2020, p. 167, https://doi.org/10.2174/1389450120666190925123507.